In vivo MPTP-induced PD mouse investigations demonstrate that MEs prevent MPTP-induced neuron loss in the substantia nigra and improve parkinsonism in MPTP-treated mice by increasing the expression level of TH and downregulating α-synuclein protein expression. Here, SNCA is linked to Parkinson disease.